What is Medtronic's market cap?

Medtronic (MDT) has a market capitalization of $105.46B and trades on NYSE.

What is Medtronic's revenue and profitability?

Medtronic generated $36.4B in trailing twelve-month revenue with net income of $4.8B, representing a net margin of 13.2%. Gross margin stands at 65.0%, with free cash flow of $5.4B. These figures are based on the Q2 2026 filing.

Who are Medtronic's competitors?

Medtronic's key competitors include Stryker Corporation, Boston Scientific, Abbott Laboratories, and others. These companies compete in similar markets and product categories.

What subsidiaries does Medtronic have?

Medtronic's subsidiaries include Mazor Robotics, Affera.

Where is Medtronic headquartered?

Medtronic is headquartered in Ireland and employs approximately 95,000 people. It has been publicly traded since 1972.

Medtronic

MDT

Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services.

Market cap

$105.46B-7.9%

Revenue$36.4B+8.4%

Net income$4.8B+3.0%

Free cash flow$5.4B+4.7%

EPS (diluted)$3.74+3.3%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q4 2026 report

June 3, 2026

Revenue$9.8BBeat by $192.1M EPS$0.96Miss by $0.58

Read the full report

Next report

Aug 18, 2026 (in a month)

Revenue estimate$9.6B

EPS estimate$1.39

Financials

Q4 2026

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation & ratios

Valuation

See full

Market cap$105.46B-7.9%

Enterprise value$132.72B-5.1%

P/E22×-2.1×

P/S2.9×-0.4×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Segments

By segment

See full

Cardiovascular$3.8B+13.8%

Neuroscience$2.8B+5.0%

Medical Surgical$2.4B+8.0%

Diabetes$838.0M+15.1%

Other Operating Segments$33.8M—

Competitors

By market cap

Johnson & Johnson$623.71B+66.9%

Abbott$164.43B-29.3%

Stryker$125.40B-16.4%

Medtronic$105.46B-6.1%

Boston Scientific$66.9B-56.5%

DexCom$28.2B-13.4%

Merit Medical Systems$4.3B-20.8%

ITG

Integer Holdings$3.1B-23.5%

By revenue growth

Boston Scientific+17.4%

DexCom+16.2%

Merit Medical Systems+11.1%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+7.9%

Abbott+6.6%

ITG

Integer Holdings+6.3%

By net margin

Johnson & Johnson21.83%-2.6pp

DexCom19.31%+6.4pp

Boston Scientific17.26%+5.7pp

Abbott13.91%-18.0pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Merit Medical Systems9.03%+0.2pp

ITG

Integer Holdings7.64%+3.2pp

Profile

Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services. The company focuses on alleviating pain and restoring health through biomedical engineering, integrating artificial intelligence and data analytics to personalize patient care. It operates a vast distribution network serving healthcare systems and physicians in more than 150 countries.

Competitive position

A leading global healthcare technology company characterized by a massive R&D pipeline and a dominant presence in cardiovascular and surgical robotics markets.

GeographiesUnited States, Western Europe, China, Japan, Ireland

Customer segmentsHospitals, Physicians, Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs)

Business modelManufacturing, Direct Sales, Consignment Inventory, Service and Support

SuppliersSpecialized component manufacturers, Raw material suppliers, Third-party R&D funding partners

CustomersHospitals, Ambulatory surgical centers, Long-term care facilities, Home care patients

CountryIreland

Listed1972

Employees95.0K

CEOGeoffrey Straub Martha

SectorHealthcare

IndustryMedical - Devices

Websitemedtronic.com

FilingsSEC EDGAR

Ask your AI about Medtronic.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's market cap?: Medtronic (MDT) has a market capitalization of $105.46B and trades on NYSE.
What is Medtronic's revenue and profitability?: Medtronic generated $36.4B in trailing twelve-month revenue with net income of $4.8B, representing a net margin of 13.2%. Gross margin stands at 65.0%, with free cash flow of $5.4B. These figures are based on the Q2 2026 filing.
Who are Medtronic's competitors?: Medtronic's key competitors include Stryker Corporation, Boston Scientific, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
What subsidiaries does Medtronic have?: Medtronic's subsidiaries include Mazor Robotics, Affera.
Where is Medtronic headquartered?: Medtronic is headquartered in Ireland and employs approximately 95,000 people. It has been publicly traded since 1972.